These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 15292526)

  • 21. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How we do it: ENT prescribing to competitive athletes--a review of current regulations.
    Mace A; Smith R; Sandhu G
    Clin Otolaryngol; 2005 Apr; 30(2):201-5. PubMed ID: 15839878
    [No Abstract]   [Full Text] [Related]  

  • 27. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in drug abuse and doping control in sport.
    Radford PF
    J R Coll Surg Edinb; 1990 Dec; 35(6 Suppl):S2-6. PubMed ID: 2079694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and accreditation of anti-doping laboratories for the Olympic Games.
    Botrè F; Wu M; Boghosian T
    Bioanalysis; 2012 Jul; 4(13):1623-31. PubMed ID: 22831478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Doping in sports].
    Jeschke J; Nekola J; Chlumský J
    Cas Lek Cesk; 1999 May; 138(10):291-7. PubMed ID: 10422337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contamination of dietary supplements and positive drug tests in sport.
    Maughan RJ
    J Sports Sci; 2005 Sep; 23(9):883-9. PubMed ID: 16195040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interview: partnering with the industry: the Olympic laboratory model.
    Cowan DA; Barker CP
    Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The toxic torch of the modern Olympic Games.
    Prendergast HM; Bannen T; Erickson TB; Honore KR
    Vet Hum Toxicol; 2003 Mar; 45(2):97-102. PubMed ID: 12678299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the health industry in the fight against doping in sport.
    Rabin O
    Forensic Sci Int; 2011 Dec; 213(1-3):10-4. PubMed ID: 21741188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma volume expanders: use in medicine and detecting misuse in sports.
    Simoni RE; Scalco FB; de Oliveira ML; Aquino Neto FR
    Bioanalysis; 2011 Jan; 3(2):215-26. PubMed ID: 21250849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.